Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-03-09 @ 12:04 PM
Study NCT ID:
NCT04823234
Status:
COMPLETED
Last Update Posted:
2021-09-28
First Post:
2021-03-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women
Sponsor:
Azienda Sanitaria-Universitaria Integrata di Udine
Organization:
Study Overview
Official Title:
Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women - "The PINK-CO Protocol"
Status:
COMPLETED
Status Verified Date:
2021-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PINK-CO
Brief Summary:
SARS-CoV-2 impact on pregnant women is not well known yet. Some authors demonstrated that lung ultrasound can give similar results if compared to chest computed tomography and better results if compared to chest x-rays without radiations and limited risks for mother and fetus.
The Lung Ultrasound Score (LUS) can be used to asses the entity and monitor the evolution of lung impairment.
Some authors described an artifact, the "light beam", as a typical ultrasound sign in COVID-19 positive patients.
With our study we hypothesize to understand the prevalence of this sign and other ultrasound signs in pregnant COVID-19 positive patients.
The Lung Ultrasound Score (LUS) can be used to asses the entity and monitor the evolution of lung impairment.
Some authors described an artifact, the "light beam", as a typical ultrasound sign in COVID-19 positive patients.
With our study we hypothesize to understand the prevalence of this sign and other ultrasound signs in pregnant COVID-19 positive patients.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: